Evidence map›Paper›PMID 26989261›Full record

ArticleBiometrika2015

Designing dose finding studies with an active control for exponential families.

Holger Dette, Katrin Kettelhake, Frank Bretz

Abstract read
In one paragraph

Article in Biometrika, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Holger DetteRuhr-Universität Bochum, Fakultät für Mathematik, 44780 Bochum, Germany.
Katrin KettelhakeRuhr-Universität Bochum, Fakultät für Mathematik, 44780 Bochum, Germany.
Frank BretzStatistical Methodology, Novartis Pharma AG, 4002 Basel, Switzerland.

Funding

Designing Efficient Designs under Model Uncertainty for Biological StudiesR01GM107639 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WONG, WENG K · 2014 to 2017
$1.0M
NIGMS NIH HHS R01 GM107639
6 · The paper itself

Abstract

In a recent paper Dette et al. (2014) introduced optimal design problems for dose finding studies with an active control. These authors concentrated on regression models with normal distributed errors (with known variance) and the problem of determining optimal designs for estimating the smallest dose, which achieves the same treatment effect as the active control. This paper discusses the problem of designing active-controlled dose finding studies from a broader perspective. In particular, we consider a general class of optimality criteria and models arising from an exponential family, which are frequently used analyzing count data. We investigate under which circumstances optimal designs for dose finding studies including a placebo can be used to obtain optimal designs for studies with an active control. Optimal designs are constructed for several situations and the differences arising from different distributional assumptions are investigated in detail. In particular, our results are applicable for constructing optimal experimental designs to analyze active-controlled dose finding studies with discrete data, and we illustrate the efficiency of the new optimal designs with two recent examples from our consulting projects.

Indexed as

active controldose estimationdose responseoptimal designs

Identifiers

PMID26989261
PMCPMC4790467

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.